Severe acute interstitial nephritis after combination immune-checkpoint inhibitor therapy for metastatic melanoma

Mostrar otras versiones (1)

Immune-checkpoint inhibitors are emerging as revolutionary drugs for certain malignancies. However, blocking the co-inhibitory signals may lead to immune-related adverse events, mainly in the spectrum of autoimmune diseases including colitis, endocrinopathies and nephritis. Here, we report a case of...

Descripción completa

Detalles Bibliográficos
Autores principales: Murakami, Naoka, Borges, Thiago J., Yamashita, Michifumi, Riella, Leonardo V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Onconephrology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886917/
https://www.ncbi.nlm.nih.gov/pubmed/27274826
http://dx.doi.org/10.1093/ckj/sfw024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886917/
https://www.ncbi.nlm.nih.gov/pubmed/27274826
http://dx.doi.org/10.1093/ckj/sfw024

Ejemplares similares